Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,528 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for OPCH. Our analysts highlight strong fundamentals and favorable market sentiment, positioning OPCH for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: OPCH is a Strong Buy candidate.
OPCH stock price ended at $21.48 on 星期四, after dropping 2.41%
On the latest trading day Jun 25, 2026, the stock price of OPCH fell by 2.41%, dropping from $22.25 to $21.48. During the session, the stock saw a volatility of 4.61%, with prices oscillating between a daily low of $21.47 and a high of $22.46. On the latest trading day, the trading volume for OPCH decreased by 88.9K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.1M shares were traded, with a market value of approximately $3.3B.